f25_062414.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 25
NOTIFICATION OF REMOVAL FROM LISTING AND/OR
REGISTRATION UNDER SECTION 12(b) OF THE
SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 001-33560
| |
Issuer: |
CAPSTONE THERAPEUTICS CORP. |
| |
Exchange: |
NASDAQ GLOBAL MARKET |
| (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered) |
| |
|
|
| |
Address: |
1275 West Washington Street, Suite 104 |
| |
|
Tempe, Arizona 85281 |
| |
Telephone Number: |
(602) 286-5520 |
(Address, including zip code, and telephone number, including area code, of Issuer’s principal executive offices)
(Description of class of securities)
Rights to Purchase 1/100 of a Share of Series A Preferred Stock
Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
o 17 CFR 240.12d2-2(a)(1)
o 17 CFR 240.12d2-2(a)(2)
o 17 CFR 240.12d2-2(a)(3)
o 17 CFR 240.12d2-2(a)(4)
o Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange.1
x Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with the rules of the Exchange and the requirements of 17 CFR 240.12d2-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
| June 24, 2014 |
|
/s/ John M. Holliman, III |
|
Executive Chairman |
|
| Date |
|
Name |
|
Title |
|
1 Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.